GMRE News

BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE:GMRE) (the “Company”) today announced the pricing of the underwritten public offering of 2,000,000 shares of its 8.00% Series B Cumulative Redeemable Preferred Stock, $0.001 par value per share (“Series B Preferred Stock”). The Series B Preferred Stock has an initial liquidation preference of $25.00 per share. The offering is expected to close on November 20, 2025, subject to customary closing conditions. The Company expects to rece

(NYSE:GMRE) BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”) announced today that its Board of Directors (“Board”) has declared the Company’s 2025 third quarter common and preferred dividends. Common Dividend The Board has declared the Company’s 2025 third quarter cash dividend of $0.75 per share of common stock and unit (the “Common Dividend”). The Common Dividend is payable on October 15, 2025, to common stockholders and unitholders of record as of September

BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), today announced that its Board of Directors (the “Board”) approved a $50 million common stock repurchase program and reverse stock split of the Company’s common stock at a ratio of one-for-five. Common Stock Repurchase Program On August 12, 2025, the Board approved a $50 million common stock repurchase program (the “Program”). Under the Program, the Company may purchase up to $50 million of its outs

BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Announces Second Quarter 2025 Financial Results